Vivanza Biosciences Ltd

Wed 23/09/2026,16:1:0 | BSE : VIVANZA

₹1.80-0.05 (-2.70%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1.85

Previous Close

₹ 1.85

Volume

10194

Mkt Cap ( ₹ Cr)

₹ 7.20

High

₹ 1.85

Low

₹ 1.80

52 Week High

₹ 2.72

52 Week Low

₹ 1.52

Book Value Per Share

₹ 1.13

Dividend Yield

₹ 0.00

Face Value

₹₹1.00

What's Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 1:25PM Voting Result for the 44th Annual General Meeting of the Company

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

    12 Sep 2026, 11:49AM Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

    11 Sep 2026, 4:04PM Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited.

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 1:25PM Voting Result for the 44th Annual General Meeting of the Company

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    12 Sep 2026, 1:25PM Voting Result for the 44th Annual General Meeting of the Company

  • Vivanza Biosciences Q1 net profit zooms 650.00% at Rs 0.15 cr

    21 Aug 2026, 11:00PM The company reported standalone net profit of Rs 0.15 crore for the quarter ended June 30, 2026 as compared to Rs 0.02 crore in the same period last y

  • Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Aug 2026, 5:20PM As of June 2026, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of Viv

  • Vivanza Biosciences - Reg. 34 (1) Annual Report.

    19 Aug 2026, 11:59AM Annual Report for the Financial Year 2025-2026 of the Company.

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026

    17 Aug 2026, 4:06PM The Board of Directors of the Company at its meeting held on Monday, August 17, 2026, at the Registered Office, inter alia, considered and approved: 1

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Notice Of The 44Th Annual General Meeting (''AGM'') And Annual Report Of The Company For The Financ

    19 Aug 2026, 11:46AM Notice of the 44th Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26

  • Vivanza Biosciences - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of

    12 Aug 2026, 6:09PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider

  • Vivanza Biosciences - Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations,

    8 Aug 2026, 11:56AM Pursuant to Regulation 32 of the SEBI(LODR) Regulation, 2015 Read with SEBI circular dated 24th December, 2019 regarding the submission of the stateme

  • Vivanza Biosciences - Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')

    7 Aug 2026, 1:29PM Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 and other items .

  • Vivanza Biosciences - Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')

    7 Aug 2026, 1:28PM Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 and other items .

  • Vivanza Biosciences - Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results

    7 Aug 2026, 1:11PM Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2026, along with year-to-date figures for the

  • Vivanza Biosciences - Update on board meeting

    31 Jul 2026, 3:19PM The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026 The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026

  • Vivanza Biosciences - Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On

    28 Jul 2026, 5:53PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider

  • Vivanza Biosciences - Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirement

    14 Jul 2026, 10:33AM we hereby declared that statutory auditor of the company M/s Shivam Soni & co, Chartered Accountant (FRN: 152477W) have issued an Audit Report with u

  • Vivanza Biosciences - Appointment of Company Secretary and Compliance Officer

    9 Jul 2026, 3:51PM pursuant to regulation 30 of the SEBI(LODR) Regulations, 2015 appointmnet of Mr. Vishal Sureshbhai Katarmal as a Company Secretary and Compliance Offi

  • Vivanza Biosciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On 09Th July, 2026.

    9 Jul 2026, 3:45PM Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations, 2015, this is to inform you that a meeting of the Board of D

  • Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 12:39PM Certificate under Regulation 47(5) of the SEBI ( Depository and Participant) Regulations, 2018, received from Purva Share Registry (I) Pvt Ltd and the

  • Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    29 Jun 2026, 3:17PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Strategic Corporation, In
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 11.8944 10.113 7.9781 10.9623 5.5128
Liabilities 11.8944 10.113 7.9781 10.9623 5.5128
Equity 4 4 4 4 4
Gross Profit 0.7093 -0.3634 0.7998 0.7212 0.049
Net Profit 0.375 -0.6951 0.3174 0.5691 0.4636
Cash From Operating Activities -1.2136 -2.4688 1.7835 0.1607 -0.6771
NPM(%) 0.33 -23.62 2.2 4 5.06
Revenue 112.231 2.9428 14.4132 14.2071 9.1475
Expenses 111.5217 3.3062 13.6134 13.4859 9.0984
ROE(%) 8.32 -15.42 7.04 12.63 10.29

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 871.35 2.55 22.22 1.06 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 116.60 0.30 1646.29 3.85 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 13.40 -4.08 0.00 7.99 -39.50 0.00
Astec Lifesciences Ltd 756.25 -4.74 0.00 4.12 -363.14 0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ